IO Biotech CEO to Act as Principal Financial Officer After CFO's Employment Termination

IO Biotech (IOBT) said Chief Executive Officer Mai-Britt Zocca will act as principal financial officer after Chief Financial Officer Keith Vendola's employment was terminated on May 9 by "mutual agreement."

The termination was not related to any disagreement with the company or its board, according to a regulatory filing on Friday.

The company appointed Brian Burkavage as its chief accounting officer, effective Thursday. Burkavage is currently the vice president of finance at IO Biotech.